Please assess the completion status of the following clinical trial:

Trial Title: Atomoxetine in the Treatment of Binge Eating Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects will meet the DSM-IV criteria for a diagnosis of binge-eating disorder for at least the last 6 months~* In addition, subjects will report at least 3 binge eating episodes per week for the last 6 months prior to randomization~Exclusion Criteria:~* Have concurrent symptoms of bulimia nervosa or anorexia nervosa~* Women who are pregnant, lactating, or of child bearing potential who are not using adequate contraceptive measures~* Patients who are displaying clinically significant suicidality or homicidality

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).